| scholarly article | Q13442814 |
| P50 | author | Antoni Gual | Q43211318 |
| P2093 | author name string | Pablo Barrio | |
| Lidia Teixidor | |||
| Magalí Andreu | |||
| P2860 | cites work | Social desirability biases in self-reported alcohol consumption and harms | Q43236902 |
| Should abstinence be the goal for alcohol treatment? Affirmative viewpoint | Q43849345 | ||
| Digital Phenotyping: Technology for a New Science of Behavior | Q43940027 | ||
| Alcohol, tobacco and health care costs: a population-wide cohort study (n = 606 947 patients) of current drinkers based on medical and administrative health records from Catalonia | Q47556840 | ||
| Filling the gap between lab and clinical impact: An open randomized diagnostic trial comparing urinary ethylglucuronide and ethanol in alcohol dependent outpatients | Q47559586 | ||
| A preliminary randomized controlled trial of contingency management for alcohol use reduction using a transdermal alcohol sensor | Q47884025 | ||
| Translating transdermal alcohol monitoring procedures for contingency management among adults recently arrested for DWI. | Q49352533 | ||
| A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity | Q72551910 | ||
| Biomonitoring for Improving Alcohol Consumption Surveys: The New Gold Standard? | Q26799851 | ||
| Social costs of illegal drugs, alcohol and tobacco in the European Union: A systematic review | Q30235136 | ||
| The effect of social desirability on reported motivation, substance use severity, and treatment attendance | Q34236137 | ||
| Predictors of detection of alcohol use episodes using a transdermal alcohol sensor | Q35596330 | ||
| Quantifying alcohol consumption: Self-report, transdermal assessment, and prediction of dependence symptoms | Q35911046 | ||
| The size and burden of mental disorders and other disorders of the brain in Europe 2010. | Q37928182 | ||
| Defining substance use disorders: do we really need more than heavy use? | Q38127407 | ||
| Ethanol metabolites: their role in the assessment of alcohol intake. | Q38581962 | ||
| Prevalence of 12-Month Alcohol Use, High-Risk Drinking, and DSM-IV Alcohol Use Disorder in the United States, 2001-2002 to 2012-2013: Results From the National Epidemiologic Survey on Alcohol and Related Conditions | Q38632136 | ||
| Experiences with SCRAMx alcohol monitoring technology in 100 alcohol treatment outpatients | Q38657525 | ||
| Patients' Knowledge and Attitudes Towards Regular Alcohol Urine Screening: A Survey Study | Q38867187 | ||
| Alcohol Consumption and Inpatient Health Service Utilization in a Cohort of Patients With Alcohol Dependence After 20 Years of Follow-up | Q38969926 | ||
| Digital phenotyping and the development and delivery of health guidelines and behaviour change interventions. | Q40214875 | ||
| Bringing patient-centered care to patients with alcohol use disorders | Q42735684 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P577 | publication date | 2019-06-05 | |
| P1433 | published in | Journal of Clinical Medicine | Q27724774 |
| P1476 | title | What Do Real Alcohol Outpatients Expect about Alcohol Transdermal Sensors? | |
| P478 | volume | 8 |
Search more.